update stocks data

njuettner · Feb 14, 2024 · cddc7a9 · cddc7a9
1 parent 1a7d014
commit cddc7a9
Show file tree

Hide file tree

Showing 7 changed files with 2,391 additions and 84 deletions.
diff --git a/data/BMY/cashflow.json b/data/BMY/cashflow.json
diff --git a/data/BMY/overview.json b/data/BMY/overview.json
@@ -1,48 +1,3 @@
 {
-    "Symbol": "BMY",
-    "AssetType": "Common Stock",
-    "Name": "Bristol-Myers Squibb Company",
-    "Description": "Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders.",
-    "CIK": "14272",
-    "Exchange": "NYSE",
-    "Currency": "USD",
-    "Country": "USA",
-    "Sector": "LIFE SCIENCES",
-    "Industry": "PHARMACEUTICAL PREPARATIONS",
-    "Address": "345 PARK AVE, NEW YORK, NY, US",
-    "FiscalYearEnd": "December",
-    "LatestQuarter": "2023-09-30",
-    "MarketCapitalization": "101229306000",
-    "EBITDA": "18448331000",
-    "PERatio": "12.89",
-    "PEGRatio": "0.671",
-    "BookValue": "14.26",
-    "DividendPerShare": "2.31",
-    "DividendYield": "0.0482",
-    "EPS": "3.86",
-    "RevenuePerShareTTM": "21.75",
-    "ProfitMargin": "0.178",
-    "OperatingMarginTTM": "0.17",
-    "ReturnOnAssetsTTM": "0.0559",
-    "ReturnOnEquityTTM": "0.267",
-    "RevenueTTM": "45006000000",
-    "GrossProfitTTM": "36378000000",
-    "DilutedEPSTTM": "3.86",
-    "QuarterlyEarningsGrowthYOY": "-0.087",
-    "QuarterlyRevenueGrowthYOY": "0.006",
-    "AnalystTargetPrice": "56.55",
-    "TrailingPE": "12.89",
-    "ForwardPE": "6.91",
-    "PriceToSalesRatioTTM": "2.249",
-    "PriceToBookRatio": "4.494",
-    "EVToRevenue": "2.954",
-    "EVToEBITDA": "7.13",
-    "Beta": "0.371",
-    "52WeekHigh": "70.68",
-    "52WeekLow": "47.58",
-    "50DayMovingAverage": "50.41",
-    "200DayMovingAverage": "58.03",
-    "SharesOutstanding": "2034760000",
-    "DividendDate": "2024-02-01",
-    "ExDividendDate": "2024-01-04"
+    "Information": "Thank you for using Alpha Vantage! Our standard API rate limit is 25 requests per day. Please subscribe to any of the premium plans at https://www.alphavantage.co/premium/ to instantly remove all daily rate limits."
 }
diff --git a/data/CHD/overview.json b/data/CHD/overview.json
@@ -12,10 +12,10 @@
     "Address": "500 CHARLES EWING BOULEVARD, EWING, NJ, US",
     "FiscalYearEnd": "December",
     "LatestQuarter": "2023-12-31",
-    "MarketCapitalization": "24623395000",
+    "MarketCapitalization": "24288338000",
     "EBITDA": "1282600000",
-    "PERatio": "32.4",
-    "PEGRatio": "3.714",
+    "PERatio": "32.32",
+    "PEGRatio": "3.705",
     "BookValue": "15.76",
     "DividendPerShare": "1.09",
     "DividendYield": "0.0115",
@@ -31,17 +31,17 @@
     "QuarterlyEarningsGrowthYOY": "-0.066",
     "QuarterlyRevenueGrowthYOY": "0.064",
     "AnalystTargetPrice": "101",
-    "TrailingPE": "32.4",
-    "ForwardPE": "28.9",
-    "PriceToSalesRatioTTM": "4.196",
-    "PriceToBookRatio": "6.32",
-    "EVToRevenue": "4.501",
-    "EVToEBITDA": "20.59",
+    "TrailingPE": "32.32",
+    "ForwardPE": "28.82",
+    "PriceToSalesRatioTTM": "4.139",
+    "PriceToBookRatio": "6.3",
+    "EVToRevenue": "4.49",
+    "EVToEBITDA": "20.54",
     "Beta": "0.535",
     "52WeekHigh": "103.21",
     "52WeekLow": "81.21",
-    "50DayMovingAverage": "95.98",
-    "200DayMovingAverage": "94.69",
+    "50DayMovingAverage": "96.06",
+    "200DayMovingAverage": "94.72",
     "SharesOutstanding": "246382000",
     "DividendDate": "2024-03-01",
     "ExDividendDate": "2024-02-14"

diff --git a/data/NVO/earnings.json b/data/NVO/earnings.json
@@ -666,14 +666,6 @@
             "estimatedEPS": "None",
             "surprise": "None",
             "surprisePercentage": "None"
-        },
-        {
-            "fiscalDateEnding": "1997-03-31",
-            "reportedDate": "1997-04-22",
-            "reportedEPS": "None",
-            "estimatedEPS": "0.02",
-            "surprise": "None",
-            "surprisePercentage": "None"
         }
     ]
 }
diff --git a/data/NVO/earnings_calendar.json b/data/NVO/earnings_calendar.json
@@ -1 +1 @@
-[{"currency":"DKK","estimate":"0.814","fiscalDateEnding":"2024-03-31","name":"Novo Nordisk","reportDate":"2024-05-02","symbol":"NVO"}]
+[{"currency":"DKK","estimate":"0.7929","fiscalDateEnding":"2024-03-31","name":"Novo Nordisk","reportDate":"2024-05-02","symbol":"NVO"}]
diff --git a/data/NVO/income.json b/data/NVO/income.json
@@ -577,7 +577,7 @@
             "investmentIncomeNet": "None",
             "netInterestIncome": "-916000000",
             "interestIncome": "2820000000",
-            "interestExpense": "2101000000",
+            "interestExpense": "-2101000000",
             "nonInterestIncome": "None",
             "otherNonOperatingIncome": "None",
             "depreciation": "None",

diff --git a/data/NVO/overview.json b/data/NVO/overview.json
@@ -12,37 +12,37 @@
     "Address": "NOVO ALLE DK 2880, BAGSVAERD DENMARK, DK",
     "FiscalYearEnd": "December",
     "LatestQuarter": "2023-12-31",
-    "MarketCapitalization": "537987351000",
+    "MarketCapitalization": "535548985000",
     "EBITDA": "109812998000",
-    "PERatio": "44.88",
-    "PEGRatio": "4.515",
+    "PERatio": "44.44",
+    "PEGRatio": "4.482",
     "BookValue": "23.9",
     "DividendPerShare": "9.4",
-    "DividendYield": "0.0085",
-    "EPS": "2.69",
+    "DividendYield": "0.0086",
+    "EPS": "2.7",
     "RevenuePerShareTTM": "51.81",
     "ProfitMargin": "0.36",
     "OperatingMarginTTM": "0.428",
     "ReturnOnAssetsTTM": "0.234",
     "ReturnOnEquityTTM": "0.881",
     "RevenueTTM": "232260993000",
     "GrossProfitTTM": "148506000000",
-    "DilutedEPSTTM": "2.69",
+    "DilutedEPSTTM": "2.7",
     "QuarterlyEarningsGrowthYOY": "0.631",
     "QuarterlyRevenueGrowthYOY": "0.37",
-    "AnalystTargetPrice": "122.98",
-    "TrailingPE": "44.88",
-    "ForwardPE": "37.74",
-    "PriceToSalesRatioTTM": "2.317",
-    "PriceToBookRatio": "35.06",
-    "EVToRevenue": "2.305",
-    "EVToEBITDA": "4.671",
+    "AnalystTargetPrice": "125.73",
+    "TrailingPE": "44.44",
+    "ForwardPE": "37.45",
+    "PriceToSalesRatioTTM": "2.306",
+    "PriceToBookRatio": "34.86",
+    "EVToRevenue": "2.31",
+    "EVToEBITDA": "4.68",
     "Beta": "0.176",
     "52WeekHigh": "121.65",
     "52WeekLow": "67.05",
-    "50DayMovingAverage": "105.43",
-    "200DayMovingAverage": "92.98",
-    "SharesOutstanding": "4456120000",
+    "50DayMovingAverage": "105.8",
+    "200DayMovingAverage": "93.17",
+    "SharesOutstanding": "4463280000",
     "DividendDate": "2024-04-02",
     "ExDividendDate": "2023-08-18"
 }